Marshall Wace North America L.P. - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$99,000
-62.2%
16,223
-73.7%
0.00%0.0%
Q2 2018$262,000
-62.5%
61,677
-61.1%
0.00%
-66.7%
Q1 2018$699,000158,5300.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,184,942$31,784,0004.70%
AWM Investment Company, Inc. 1,562,517$9,578,0001.67%
Opaleye Management Inc. 420,000$2,574,0000.91%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0000.75%
GENERAL AMERICAN INVESTORS CO INC 867,600$5,318,0000.50%
Grandeur Peak Global Advisors, LLC 538,363$3,300,0000.50%
Redmond Asset Management, LLC 55,941$343,0000.16%
WOODSTOCK CORP 88,303$541,0000.10%
CADENCE CAPITAL MANAGEMENT LLC 173,808$1,065,0000.07%
Sheaff Brock Investment Advisors, LLC 71,000$435,0000.06%
View complete list of ARATANA THERAPEUTICS INC shareholders